Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights
February 12, 9:05 AM
Gainers SeaStar Medical Holding (NASDAQ:ICU) shares rose 27.9% to $1.1 during Monday’s pre-market session. The company’s market cap…

AIH

Read More
1 minute read
  • News

AN2 Therapeutics to Voluntarily Pause Enrollment in Phase 3 Part of Phase 2/3 Pivotal Clinical Trial Evaluating Epetraborole for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease

By Benzinga Newsdesk
February 12, 7:46 AM
AN2 Therapeutics, Inc. (NASDAQ:ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced the

ANTX

Read More
2 minute read
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Short Ideas
  • Small Cap
  • Trading Ideas

Top 5 Health Care Stocks That May Fall Off A Cliff

By Lisa Levin
September 6, 8:31 AM
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

ANTX

Read More
2 minute read
  • Insider Trades
  • Long Ideas
  • Markets
  • News
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

$16M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying

By Lisa Levin
August 23, 7:58 AM
Although U.S. stocks closed mostly lower on Tuesday, there were a few notable insider trades.

ANTX

Read More
3 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights
August 17, 1:31 PM
Gainers PhenomeX (NASDAQ:CELL) shares increased by 136.4% to $0.95 during Thursday’s regular session. As of 13:31 EST, PhenomeX’s…

ADTX

Read More
1 minute read
  • News
  • Offerings

AN2 Therapeutics Announces Pricing Of $70M Underwritten Offering Of 7,777,778 Shares Of Common Stock At A Price Of $9/Share

By Happy Mohamed
August 16, 12:17 AM
AN2 Therapeutics, Inc. (NASDAQ:ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced the pricing of

ANTX

Read More
3 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights
May 16, 1:31 PM
Gainers AN2 Therapeutics (NASDAQ:ANTX) stock moved upwards by 23.0% to $6.71 during Tuesday’s regular session. The company’s market…

ANTX

Read More
7 minute read
  • Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights
May 5, 1:54 PM
  Friday's session saw 100 companies set new 52-week lows.

ACRX

Read More
33 minute read
  • Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
May 4, 12:29 PM
  On Thursday, 498 companies reached new 52-week lows.

ABCB

Read More
2 minute read
  • General
  • Health Care
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Short Ideas
  • Small Cap
  • Trading Ideas

Top 5 Health Care Stocks That May Dip

By Lisa Levin
January 27, 7:33 AM
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

ANTX

Posts pagination

Previous 1 2 3 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service